Worth reading
68In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Deterioration
Direction inferred from the company’s description.Scale
-1264
¥ million (decrease in consolidated revenue)Wording
Avoiding a definitive answer
How definitive the wording is.Revised forecast
2024 年４月期 · Full yearPrevious forecast published 2023 年６月 13 日Net SalesConsolidated9,507→8,242millions
-13.3%
Net SalesIndividual7,590→6,527millions
-14.0%
Operating profitConsolidated536→291millions
-45.6%
Operating profitIndividual464→252millions
-45.5%
Ordinary incomeConsolidated565→308millions
-45.4%
Ordinary incomeIndividual516→300millions
-41.8%
Profit attributable to owners of the parentConsolidated385→187millions
-51.3%
Profit attributable to owners of the parentIndividual362→209millions
-42.1%
Net income per shareConsolidated67.92→33.04yen
-51.4%
Net income per shareIndividual63.91→36.94yen
-42.2%
The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Reason for the revision
防護服・環境資機材事業では感染症分野の需要が比較的落ち着き、安全環境設備分野や高視認防護服・難燃防護服など新事業の業容拡大が遅れ、年度末の需要が前期を下回った。ヘルスケア製品事業では小売店の在庫調整により生産量を一時的に調整し、円安の進行等に伴う資材価格の高騰も影響した。
Previous-period resultsConsolidated Net Sales 9,081 / Operating profit 531 / Ordinary income 562 / Profit attributable to owners of the parent 406 / Net income per share 71.96 / Individual Net Sales 7,383 / Operating profit 456 / Ordinary income 489 / Net income for the current fiscal year 362 / Net income per share 64.12
Dividend forecast revision修正なし（期末配当予想は1株当たり23.00円）
Consolidated / non-consolidatedConsolidated and standalone
| Item | Details |
|---|---|
| Net Sales | Consolidated 9,507 / Individual 7,590 → Consolidated 8,242 / Individual 6,527（Consolidated -13.3 / Individual -14） |
| Operating profit | Consolidated 536 / Individual 464 → Consolidated 291 / Individual 252（Consolidated -45.6 / Individual -45.5） |
| Ordinary income | Consolidated 565 / Individual 516 → Consolidated 308 / Individual 300（Consolidated -45.4 / Individual -41.8） |
| Profit attributable to owners of the parent | Consolidated 385 / Individual 362 → Consolidated 187 / Individual 209（Consolidated -51.3 / Individual -42.1） |
| Net income per share | Consolidated 67.92 / Individual 63.91 → Consolidated 33.04 / Individual 36.94 |
| Fiscal Period Covered | 2024 年４月期 |
| Period Covered | Full year |
| Publication date of previous forecast | 2023 年６月 13 日 |
| Previous-period results | Consolidated Net Sales 9,081 / Operating profit 531 / Ordinary income 562 / Profit attributable to owners of the parent 406 / Net income per share 71.96 / Individual Net Sales 7,383 / Operating profit 456 / Ordinary income 489 / Net income for the current fiscal year 362 / Net income per share 64.12 |
| Reason for the revision | 防護服・環境資機材事業では感染症分野の需要が比較的落ち着き、安全環境設備分野や高視認防護服・難燃防護服など新事業の業容拡大が遅れ、年度末の需要が前期を下回った。ヘルスケア製品事業では小売店の在庫調整により生産量を一時的に調整し、円安の進行等に伴う資材価格の高騰も影響した。 |
| Dividend forecast revision | 修正なし（期末配当予想は1株当たり23.00円） |
| Consolidated / non-consolidated | Consolidated and standalone |
Items this document does not state (1)
Details and amount of extraordinary loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.防護服・環境資機材事業では、感染症分野の需要が落ち着き、安全環境設備分野や高視認防護服・難燃防護服など新事業の拡大が遅れ、年度末の需要が前期を下回ったため。ヘルスケア製品事業では小売店の在庫調整に伴う生産量調整と、円安などによる資材価格高騰が影響したため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.